Guillén-Del Castillo Alfredo, Callejas-Moraga Eduardo L, García Gabriela, Rodríguez-Palomares José F, Román Antonio, Berastegui Cristina, López-Meseguer Manuel, Domingo Enric, Fonollosa-Plá Vicente, Simeón-Aznar Carmen Pilar
Department of Systemic Autoimmune Diseases, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Passeig Vall d'Hebron 119-129, PC: 08035, Barcelona, Spain.
Department of Cardiology, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
Arthritis Res Ther. 2017 Jun 14;19(1):135. doi: 10.1186/s13075-017-1327-8.
Pulmonary arterial hypertension (PAH) is one of the most relevant causes of death in systemic sclerosis. The aims of this study were to analyse the recently published DETECT algorithm comparing it with European Society of Cardiology/European Respiratory Society (ESC/ERS) 2009 guidelines: as screening of PAH; (2) identifying median pulmonary arterial pressure (mPAP) ≥21 mmHg; and (3) determining any group of pulmonary hypertension (PH).
Eighty-three patients fulfilling LeRoy's systemic sclerosis diagnostic criteria with at least right heart catheterization were studied retrospectively. Clinical data, serological biomarkers, echocardiographic and hemodynamic features were collected. SPSS 20.0 was used for statistical analysis.
According to right heart catheterization findings, 35 patients with PAH and 28 with no PH met the standards for DETECT algorithm analysis: 27.0% of patients presented with functional class III/IV. Applying DETECT, the sensitivity was 100%, specificity 42.9%, the positive predictive value 68.6% and the negative predictive value 100%, whereas employing the ESC/ERS guidelines these were 91.4%, 85.7%, 88.9% and 89.3%, respectively. There were no missed diagnoses of PAH using DETECT compared with three patients missed (8.5%) using ESC/ERS guidelines. The DETECT algorithm also showed greater sensitivity and negative predictive value to identify patients with mPAP ≥21 mmHg or with any type of PH.
The DETECT algorithm is confirmed as an excellent screening method due to its high sensitivity and negative predictive value, minimizing missed diagnosis of PAH. DETECT would be accurate either for early diagnosis of borderline mPAP or any group of PH.
肺动脉高压(PAH)是系统性硬化症最主要的死亡原因之一。本研究旨在分析最近发表的DETECT算法,并将其与欧洲心脏病学会/欧洲呼吸学会(ESC/ERS)2009年指南进行比较:(1)作为PAH的筛查方法;(2)识别平均肺动脉压(mPAP)≥21 mmHg的患者;(3)确定任何类型的肺动脉高压(PH)患者群体。
回顾性研究了83例符合勒罗伊系统性硬化症诊断标准且至少接受过右心导管检查的患者。收集了临床数据、血清生物标志物、超声心动图和血流动力学特征。使用SPSS 20.0进行统计分析。
根据右心导管检查结果,35例PAH患者和28例无PH患者符合DETECT算法分析标准:27.0%的患者为功能分级III/IV级。应用DETECT算法时,敏感性为100%,特异性为42.9%,阳性预测值为68.6%,阴性预测值为100%;而采用ESC/ERS指南时,这些指标分别为91.4%、85.7%、88.9%和89.3%。与使用ESC/ERS指南漏诊3例患者(8.5%)相比,使用DETECT算法未漏诊PAH患者。DETECT算法在识别mPAP≥21 mmHg或任何类型PH患者方面也显示出更高的敏感性和阴性预测值。
DETECT算法因其高敏感性和阴性预测值,最大限度地减少了PAH的漏诊,被确认为一种优秀的筛查方法。DETECT对于临界mPAP或任何类型PH的早期诊断都将是准确的。